Extended Injection Intervals after Switching from Ranibizumab to Aflibercept in Macular Edema due to Central Retinal Vein Occlusion

PURPOSE: To assess treatment interval extension after switching from ranibizumab to aflibercept intravitreal injections in macular edema (ME) due to central retinal vein occlusion (CRVO) with an insufficient response or frequent recurrences to initial treatment. METHODS: CRVO eyes treated with ranib...

Full description

Saved in:
Bibliographic Details
Published in:J Ophthalmol
Main Authors: Nghiem-Buffet, Sylvia, Glacet-Bernard, Agnès, Addou-Regnard, Manar, Souied, Eric H., Cohen, Salomon Y., Giocanti-Auregan, Audrey
Format: Artigo
Language:Inglês
Published: Hindawi 2018
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6079418/
https://ncbi.nlm.nih.gov/pubmed/30116635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8656495
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items